Drug stock soars 400% after Martin Shkreli buys it in 'CNN Money', Paul R. La Monica, November 20, 205
Excerpts: " Remember Martin Shkrekeli? The hedge fund manager turned pharmaceutical executive who became the center of a debate on drug prices after his firm Turing raised the cost of a drug used by AIDS patients by over 5,000% from $13.50 a pill to $750? Well, he just bought a majority stake in another drug company ... and shares of it surged 400% on the news."
My cmments: Shkreli was the greedy guy who hiked the price of Daraprim by 5,500%.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.